The score fell 1 point, mainly due to valuation and price changes. Price rose 0.1%, from $80.07 to $80.17. Reported EPS was unchanged, so the higher price reduced valuation support.

The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Historical cheapness: current PE is 13.3× versus the full-history median of 8.7× shown in the valuation table, producing 24.1/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 31.2/100. The model applies a 32.3% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 8.9× (18-month half-life). The favorable scenario uses 11.2× PE and $8.6 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Business trends are mixed. Over the past year: revenue +10.3%, earnings -12.5%, operating margin -1.3 percentage points. Free cash flow is 8.9% of revenue. The business score is 55.1/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $8.63 of EPS and a 11.2× PE, suggesting a share price of about $96.25. Valuation history and outlook inform the PE.

The displayed favorable scenario is 20.4% upside, or about $96.21.

This is a scenario based on our model, not a forecast or probability.

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $5.22 of EPS and a 10.4× PE, suggesting a share price of about $54.05 — 32% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

The score rose 2 points, mainly due to valuation and price changes. Price rose 9.1%, from $257.08 to $280.53.

Valuation and price changes added 2.4 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Historical cheapness: current PE is 58.2× versus the full-history median of 71.5× shown in the valuation table, producing 63.9/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 74.1/100. The model applies a 38.8% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 71.1× (18-month half-life). The favorable scenario uses 74× PE and $6.6 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Business trends are strong. Over the past year: revenue +26.2%, earnings +111.5%, operating margin +1.7 percentage points. Free cash flow is 25.5% of revenue. The business score is 82.5/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $6.59 of EPS and a 74× PE, suggesting a share price of about $488.00. Valuation history and outlook inform the PE.

The displayed favorable scenario is 89.8% upside, or about $487.90.

This is a scenario based on our model, not a forecast or probability.

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $3.91 of EPS and a 52.3× PE, suggesting a share price of about $204.47 — 21% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.